$INV

Innventure, Inc. (INV): Submission of Matters to a Vote of Security Holders

Innventure, Inc. (INV) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. innv-20260617 0002001557 False 0002001557 2026-04-29 2026-04-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securitie

Original reporting
Published Jun 18, 2026, 9:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$INV
Neutral
high confidence
Mentioned
$INV
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INVNeutralLow
01

Why it matters

The disclosure confirms election of three Class II directors and ratification of Withum Smith+Brown, P.C. as independent auditor for FY ending Dec. 31, 2026; no additional corporate actions are stated.

02

Market read

Primarily a procedural governance update; traders typically treat as low-catalyst unless tied to a broader event (not present here).

03

What to watch

The filing includes vote counts and broker non-votes, but without context (e.g., activist involvement, resignation, or auditor change) it is unlikely to drive trading decisions.

Relevance 6/10Novelty 2/10Timing: Filed June 18, 2026 after the June 17, 2026 annual meeting vote results.

Background

The company submitted an SEC Form 8-K under Item 5.07 to report matters voted on at its 2026 Annual Meeting.

Company-level read

Ticker impact

$INVNeutralHigh confidence
Context

Innventure filed an 8-K reporting the June 17, 2026 annual meeting vote results, including director elections and auditor ratification.

Expected impact

Limited near-term impact; any reaction likely confined to low-liquidity sentiment rather than fundamentals.

Evidence & confidence

The filing is a standard Item 5.07 disclosure of voting results (board nominees and independent auditor ratification) without new earnings, deal, or regulatory developments.

Market effects

None—no sector-wide regulatory, operational, or financial datapoints.

None—no macro or cross-regional catalyst described.

None—purely company-specific governance voting results.

Counterpoint

If the vote results imply contested governance or auditor opposition, it could marginally affect sentiment, but the filing provides no narrative or consequences.

Key entities

  • Innventure, Inc.

    Subject of the SEC 8-K; reported annual meeting voting outcomes.

  • Withum Smith+Brown, P.C.

    Independent registered public accounting firm ratified for fiscal year ending Dec. 31, 2026.

  • Bruce Brown / John Hewitt / Catriona Fallon

    Class II director nominees elected for terms expiring at the 2029 annual meeting.

Related articles

$INVMed

Innventure, Inc. (INV): Results of Operations and Financial Condition

Innventure, Inc. (INV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991innventure-2q26earning.htm EX-99.1 Document Exhibit 99.1 Innventure Reports Second Quarter 2026 Results Accelsius focused on execution against foundational milestones to strengthen path to scaled two-phase adoption ORLANDO, Fla., August 13, 2026 (GLOBAL NEWSWIRE) –

$INVMed

Placing and Offer for Subscription

The Board of The Investment Company plc (LSE: INV) published a circular to shareholders on 4 June 2026 outlining proposals for the company’s future. Plans include appointing Dowgate Wealth Limited as portfolio manager, adopting a new scarcity/resilience-focused investment policy, raising funds via a placing and offer for subscription, and providing a 100% exit option for qualifying shareholders not wishing to stay. Proposals require shareholder approval.

$INVMedAI 9/10

Innventure (INV) Q4 2025 Earnings Transcript

Innventure (INV) reported 2025 revenue of $2.1m vs. $1.2m in 2024, driven by Accelsius and AeroFlexx. Accelsius delivered $1.6m revenue (vs. $0.3m) and secured $50m+ in new Q1 bookings; Accelsius Series B closed at a ~$665m post-money valuation. Management expects Accelsius to be cash-flow positive by year-end. Cash rose to $65.4m; adjusted EBITDA loss was $78.8m.

$MPLTMedAI 8/10

MapLight Raises $150 M PIPE To Fund CNS Pipeline

MapLight Therapeutics (MPLT) priced a $150 million PIPE, selling 9.2M shares at $11.38 and 4.0M pre-funded warrants at $11.3799, exercisable at $0.0001 with no expiration. Proceeds will fund CNS drug ML-007C-MA, including VISTA Phase 2 in Alzheimer’s disease psychosis and ZEPHYR-2 Phase 3 in schizophrenia. Closing expected Aug. 14, 2026.

$TSNMedAI 8/10

Tyson Foods will close or sell three US beef facilities as industry struggles

Tyson Foods said it will close or sell three US beef facilities, ending operations at Joslin, Illinois and Eagle Mountain, Utah, and pursuing the sale of Pasco, Washington, while shifting capacity to other sites. The move follows prior Tyson beef shutdowns and comes as a 75-year cattle supply trough drives losses. Tyson forecast a $500m to $650m adjusted beef operating loss for fiscal 2026.

$MVISMedAI 8/10

MicroVision, Inc.: MicroVision Announces Launch of Proposed Public Offering

MicroVision (NASDAQ:MVIS) said it has commenced a proposed public offering of units, each unit consisting of one share of common stock (or a pre-funded warrant in lieu) and one warrant to buy one share. MicroVision will sell the shares and warrants, with final terms to be set at pricing. Net proceeds are for general corporate purposes, including working capital and capex.